ATE318075T1 - Hepatoblasten und verfahren zu ihrer isolierung - Google Patents

Hepatoblasten und verfahren zu ihrer isolierung

Info

Publication number
ATE318075T1
ATE318075T1 AT95903543T AT95903543T ATE318075T1 AT E318075 T1 ATE318075 T1 AT E318075T1 AT 95903543 T AT95903543 T AT 95903543T AT 95903543 T AT95903543 T AT 95903543T AT E318075 T1 ATE318075 T1 AT E318075T1
Authority
AT
Austria
Prior art keywords
hepatoblasts
methods
isolation
relates
well
Prior art date
Application number
AT95903543T
Other languages
English (en)
Inventor
Lola M Reid
Samuel H Sigal
Shlomo Brill
Patricia A Holst
Original Assignee
Einstein Coll Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Einstein Coll Med filed Critical Einstein Coll Med
Application granted granted Critical
Publication of ATE318075T1 publication Critical patent/ATE318075T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95903543T 1993-11-19 1994-11-16 Hepatoblasten und verfahren zu ihrer isolierung ATE318075T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15593993A 1993-11-19 1993-11-19

Publications (1)

Publication Number Publication Date
ATE318075T1 true ATE318075T1 (de) 2006-03-15

Family

ID=22557387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95903543T ATE318075T1 (de) 1993-11-19 1994-11-16 Hepatoblasten und verfahren zu ihrer isolierung

Country Status (10)

Country Link
EP (2) EP0729297B1 (de)
JP (2) JPH09505206A (de)
AT (1) ATE318075T1 (de)
AU (1) AU1256395A (de)
CA (1) CA2177043C (de)
DE (1) DE69434637T2 (de)
ES (1) ES2260759T3 (de)
IL (1) IL111693A (de)
WO (1) WO1995013697A1 (de)
ZA (1) ZA949180B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0953633A1 (de) * 1998-04-28 1999-11-03 Livercell L.L.C. Zellkulturverfahren und Medium zur Herstellung von vermehrungsfähige, normale, differenzierte Humane Leberzellen
AU779706B2 (en) 1999-01-19 2005-02-10 University Of North Carolina At Chapel Hill, The Human liver progenitors
US7456017B2 (en) 1999-10-01 2008-11-25 University Of North Carolina At Chapel Hill Processes for clonal growth of hepatic progenitor cells
US20020187133A1 (en) 1999-10-01 2002-12-12 Hiroshi Kubota Methods of isolating bipotent hepatic progenitor cells
WO2001053462A1 (en) * 2000-01-19 2001-07-26 University Of North Carolina At Chapel Hill Liver tissue source
CN1461341A (zh) * 2000-10-03 2003-12-10 北卡罗来纳大学 肝祖先细胞克隆生长的方法
MXPA03008882A (es) 2001-03-27 2003-12-08 Vertex Pharma Composiciones y metodos utiles para la infeccion por hcv.
ATE371018T1 (de) 2001-06-22 2007-09-15 Stemcells Inc Le-zellen (liver engrafting cells), assays und verwendungen davon
HUE032238T2 (en) * 2002-03-15 2017-09-28 Univ North Carolina Chapel Hill Primitive and proximal liver stem cells
JP7386539B2 (ja) * 2018-08-03 2023-11-27 株式会社細胞応用技術研究所 培養上清製剤の製造方法
CN112912087A (zh) * 2018-09-14 2021-06-04 卢卡科学株式会社 线粒体向淋巴器官中的移植以及用于该移植的组合物
CN113046304B (zh) * 2021-04-09 2023-05-16 四川大学华西医院 一种线粒体的分离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition
WO1993003142A1 (en) * 1991-08-07 1993-02-18 Albert Einstein College Of Medicine Proliferation of hepatocyte precursors
ES2157225T3 (es) * 1992-10-09 2001-08-16 Advanced Tissue Sciences Inc Celulas hepaticas de reserva.

Also Published As

Publication number Publication date
DE69434637T2 (de) 2006-09-21
EP0729297B1 (de) 2006-02-22
JPH09505206A (ja) 1997-05-27
EP1688037A2 (de) 2006-08-09
ES2260759T3 (es) 2006-11-01
DE69434637D1 (de) 2006-04-27
IL111693A0 (en) 1995-01-24
EP1688037A3 (de) 2006-12-13
EP0729297A1 (de) 1996-09-04
IL111693A (en) 2001-01-28
CA2177043C (en) 2011-08-09
ZA949180B (en) 1995-07-26
WO1995013697A1 (en) 1995-05-26
JP2004339227A (ja) 2004-12-02
EP0729297A4 (de) 2004-05-06
AU1256395A (en) 1995-06-06
CA2177043A1 (en) 1995-05-26

Similar Documents

Publication Publication Date Title
ATE318075T1 (de) Hepatoblasten und verfahren zu ihrer isolierung
EP0871771A4 (de) Verfahren und zusammensetzungen zur durchführung der homologen rekombination
ATE206072T1 (de) Verfahren zur herstellung von mikrokapselhaltigen zusammensetzungen
DE59607405D1 (de) Magnetventil sowie Verfahren zu dessen Herstellung
AT399887B (de) Verfahren zum herstellen von kaltgepressten eisenhältigen briketts
DE69534886D1 (de) Verfahren zur Isolierung von Zellkomponenten
ATE203993T1 (de) Verfahren zur isolierung von galanthamin
DE69610125D1 (de) Verfahren zur herstellung von viskoelastischen zusammensetzungen
ATE204120T1 (de) Verfahren zur vermehrung von pflanzenmaterial
ATE205425T1 (de) Verfahren zur behandlung von festen abfällen
DE69003944D1 (de) Verfahren zur gesteuerten anaeroben zersetzung von abfall.
DE69425497D1 (de) Verfahren zum anreichern von löslichen ballaststoffen
DE69605902D1 (de) Verfahren zur stabilisierung von schlamm
DE69526796D1 (de) Verfahren zur inhibierung von pflanzenkrankheiten
DE69533590D1 (de) Verfahren zur herstellung von feinteiligen festen builderpartikeln
DE59611017D1 (de) Verfahren zur herstellung von n-substituierten 3-hydroxypyrazolen
FI914132A7 (fi) Menetelmä pienen rasvapitoisuuden omaavien koostumusten uuttamiseksi biologista alkuperää olevista aineista
DE59407708D1 (de) Verfahren zur herstellung von homo- und copolymerisaten von alk-1-enen
ATE174954T1 (de) Verfahren zur herstellung von granularen waschmittelkomponenten oder waschmittelzusammensetzungen
DE59807503D1 (de) Verfahren zur herstellung von erdalkalidiorganylverbindungen
ATE223259T1 (de) Verfahren zur wiedergewinnung von sekundärrohstoffen aus restmüll und reststoffen
DE69402880D1 (de) Verfahren zur herstellung von alkylglykosiden
DE69636644D1 (de) Verfahren zur herstellung von granularen waschmittelkomponenten oder -zusammensetzungen
DE69403611D1 (de) Verfahren zur herstellung von homogenem magnetit
DE69324039D1 (de) Verfahren zur kaseinfertigung von leder

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0729297

Country of ref document: EP

REN Ceased due to non-payment of the annual fee